Member login
Idarucizumab is a monoclonal antibody fragment with high affinity for dabigatran reversing its anticoagulant effects within minutes. Patients with acute ischemic stroke on dabigatran treatment may become eligible for thrombolysis with rt-PA. In patients on dabigatran with intracerebral hemorrhage idarucizumab could prevent lesion growth. Carmen Lahiff-Jenkins, Managing Editor of the International Journal of Stroke spoke to Dr Pawel Kermer from Krankenhaus Sanderbusch; Neurology, Sande Germany.
Read the article link here
- Calling All Future Stroke Leaders
- Words from the President on stroke care during the COVID19 pandemic
- World Stroke Academy content is NOW available free online to all
- Global Stroke Leaders Launch Radical Prevention Strategy
- The Global Impact of COVID-19 on Stroke - the latest results from the survey from Prof. Marc Fischer, WSO President-Elect
- Reduced rates for your attendance at ESO-WSO 2020
- Get ready to Join the MoveMent!
- Global Stroke Leaders Launch Radical Prevention Strategy
- World Stroke Day 2020 News Release
- No Time for Silence on Stroke Prevention
- WSO Brain and Heart Week
- The latest World Stroke Academy news
- Accuracy in BP Measurement and Effective Hypertension Control Promoted on World Hypertension Day
- The 74th World Health Assembly - 24-31 May
- The state of stroke services across the globe: report of World Stroke Organization
- WHO releases priority list of medical devices and interventions for stroke
- World Stroke Day Campaign website and toolkit LIVE
- WSO welcomes WHO recommendations on management of hypertension
- The World Stroke Academy newly branded website is live!
- 5 ways you can support the #Precioustime campaign on World Stroke Day
- GCCH Position Paper “Preventing the next pandemic: The case for investing in circulatory health”
- Global survey reveals only 35% hospitals worldwide provide life-saving stroke treatment
- How to save $1 trillion
- WSO Global Stroke Fact Sheet 2022
- World Stroke Campaign Award Shortlist Announced
- ICD-11 is now officially in effect
- World Stroke Organization’s statement on Ukraine
- WSO Annual Report for 2021
- Get Ready for World Stroke Day 2022 - The Power of Saving #Precioustime
- WHO Strategic Technical Advisory Group meeting on Global Noncommunicable diseases action plan 2013-2030
- WSO Calls for changes in primary prevention guidelines for cardiovascular disease and stroke
- WSO Future Stroke Leaders Programme - Cohort 2 Announcement
- Building Momentum around Implementation of Quality Stroke Care – update from the WSO Rede Brasil AVC Global Stroke Alliance Meeting, Sao Paulo
- World Stroke Day 2022 Raising public awareness of stroke signs and the importance of #Precioustime
- Countdown to World Stroke Day- key actions for members and partners!
- WSO is announcing the results from the Officers elections 2022
- World Stroke Organization Tackle Gaps in Access to Quality Stroke Care
- WSC 2022: One Voice for Stroke
- World Stroke Day #Precioustime Campaign Evaluation
- In memoriam of Dr. Ralph L. Sacco
- WHO Executive Board (EB 152)
- RES-Q + Using digitization and artificial intelligence to improve healthcare
- Be the storyteller of 2023. Submit your abstract at WSC 2023!
- Summary of systematic review and synthesis of global stroke guidelines on behalf of WSO
- World Health Assembly (WHA76)
- World Stroke Day 2023 - Together we are #GreaterThan Stroke
- THE ROAD TO UHC: WHY INTEGRATION OF CIRCULATORY HEALTH INTERVENTIONS IN PRIMARY CARE IS ESSENTIAL
- Global Declaration on Stroke Commitments for Facing Stroke
- NEW World Stroke Campaign Website goes LIVE!
- Global Declaration on Stroke Commitments for Facing Stroke: New Delhi, India – September 8th, 2023
- TOGETHER WE CAN BE #GreaterThan STROKE!
- The Global Stroke Community Reunited for the WSC 2023
- Join the Future Stroke Leaders Success Journey – Cohort 3 Applications Open
- The RES-Q platform has officially launched!
- New Trial Expands Window For Stroke Thrombectomy With Simpler Imaging
- Now available: WSA Big Data & Stoke e-Learning module
- World Stroke Day 2024
- World Stroke Campaign Award 2023 Winners
- Homepage
- Vision and strategy
- Board and Executive Committee
- Privacy policy
- Terms of use
- SEO sitemap
- Global Stroke Corner
- Words from the President: LOOKING AHEAD
- WSO Publishes Global Stroke Fact Sheet
- WSO Call for Editor-in-Chief of IJS
- WSO Membership - Call for Dues 2019
- ESO-WSO Conference 2020
- XXII Ibero-American Stroke Organization Congress
- Asia Pacific Stroke Conference 2019
- European Master in Stroke Medicine - Feedback from WSO scholarships recipients
- Philippine Nationwide Stroke Training, 2018
- Advances in neuroscience & new strategies for preventing & treating brain diseases, November 2018, Moscow
- International conference on essentials of stroke care, November 2018, India
- Education Committee Update
- SSO Committee March 2019
- Stroke Guidelines & Quality Committee Update
- WSO Research Committee Update
- WSO and Global Policy – Key Events in 2019
- Report of WHO Global Forum on Medical Devices
- Report from the WHO’s Executive Board in Geneva January 24th to February 1st, 2019
- WSO President and Romanian Health Minister sign a Memorandum of Understanding
- First Stroke Summer School in Latin America
- Stroke Thrombolysis Master Class-2018: A Report
- Welcome to New Members
- Heart and Stroke Foundation of Canada Publishes a New Report
- On the International Women’s Day, March 8, WSO celebrated women in stroke!
- News from the European Stroke Organization
- Marie-Germaine Bousser receives the 2019 Brain Prize
- Mongolian Stroke Association celebrates 10 years of action
- News
- Contact us
- About WSO
- Congratulations to Thomas Fischer, Angels Project Lead
- Words from the President
- Global Stroke Corner
- Angels Awards
- A message from BMS Pfizer
Our partners and sponsors
Achieving our vision of a life free from stroke is a task that WSO cannot achieve alone. We are committed to building our partnerships at the global, regional and national level to scale up and deliver improvements in prevention, treatment and support to reduce the burden of stroke.
Platinum Plus
Silver
Platinum Plus
Silver
Bronze
Bronze
Bronze
Corporate Supporters
Bronze
Bronze
Silver
Corporate Supporters